Results 1 to 10 of about 11,837,947 (410)

Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 [PDF]

The Lancet Respiratory Medicine, 2020
Background: Previous attempts to characterise the burden of chronic respiratory diseases have focused only on specific disease conditions, such as chronic obstructive pulmonary disease (COPD) or asthma.
GBD Chronic Respiratory Disease Collaborators, Violante FS   +1 more
core   +2 more sources

Pulmonary Rehabilitation for Adults with Chronic Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline

American Journal of Respiratory and Critical Care Medicine, 2023
Background Despite the known benefits of pulmonary rehabilitation (PR) for patients with chronic respiratory disease, this treatment is underused. Evidence-based guidelines should lead to greater knowledge of the proven benefits of PR, highlight the role
C. Rochester, J. Alison, B. Carlin, A. Jenkins, N. Cox, G. Bauldoff, S. Bhatt, J. Bourbeau, C. Burtin, P. Camp, T. Cascino, Grace Anne Dorney Koppel, C. Garvey, R. Goldstein, D. Harris, L. Houchen-Wolloff, T. Limberg, P. Lindenauer, M. Moy, C. Ryerson, Sally J. Singh, M. Steiner, Rachel S. Tappan, A. Yohannes, A. Holland   +24 more
semanticscholar   +1 more source

Pyroptosis in inflammation-related respiratory disease

Journal of physiology and biochemistry, 2022
Pyroptosis is commonly induced by the gasdermin (GSDM) family and is accompanied by the release of inflammatory cytokines such as IL-1β and IL-18. Recently, increasing evidence suggests that pyroptosis plays a role in respiratory diseases.
Yuanyu Feng, Min Li, Xiaoting Yangzhong, Xifeng Zhang, Anju Zu, Yunjiao Hou, Lin Li, Shibo Sun   +7 more
semanticscholar   +1 more source

A new coronavirus associated with human respiratory disease in China

Nature, 2020
Emerging infectious diseases, such as severe acute respiratory syndrome (SARS) and Zika virus disease, present a major threat to public health1–3.
Fan Wu, Su Zhao, Bin Yu, Yan-Mei Chen, Wen Wang, Zhigang Song, Y. Hu, Zhaowu Tao, Jun-hua Tian, Yuan-Yuan Pei, Mingli Yuan, Yuling Zhang, Fahui Dai, Yi Liu, Qimin Wang, Jiao-Jiao Zheng, Lin Xu, E. Holmes, Yong‐Zhen Zhang   +18 more
semanticscholar   +1 more source

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

Journal of Emergency Medicine, 2020
Importance Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that was first reported in Wuhan, China, and has subsequently spread worldwide.
Chao-min Wu, Xiaoyan Chen, Yanping Cai, Jia’an Xia, Xiaoping Zhou, Shan Xu, Hanping Huang, Li Zhang, Xia Zhou, C. Du, Yuye Zhang, Juan Song, Sijiao Wang, Yencheng Chao, Zeyong Yang, Jie Xu, Xin Zhou, Dechang Chen, W. Xiong, Lei Xu, F. Zhou, Jinjun Jiang, C. Bai, Junhua Zheng, Yuanlin Song   +24 more
semanticscholar   +1 more source

Respiratory disease in pregnancy [PDF]

Obstetrics, Gynaecology & Reproductive Medicine, 2007
Breathlessness in the absence of an underlying pathology is common in pregnancy. Asthma affects about 7% of women of childbearing age. Treatment is the same as for the non-pregnant population and most drugs are safe in pregnancy. Educating women to continue preventer inhaled corticosteroid therapy will reduce the risk of attacks. Respiratory infections
S Stone, Catherine Nelson-Piercy
openaire   +3 more sources

Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma

Respiratory Research, 2022
Background Whether cysteinyl-leukotriene receptor antagonists (LTRAs) have a similar antitussive effect to inhaled corticosteroids and long-acting β2-agonist (ICS/LABA), and that LTRA plus ICS/LABA is superior to LTRAs alone or ICS/LABA alone in treating
Fang Yi, Chen Zhan, Baojuan Liu, Hu Li, Jianmeng Zhou, Jiaman Tang, Wen Peng, Wei Luo, Qiaoli Chen, Kefang Lai   +9 more
doaj   +1 more source

Diagnostic procedure for idiopathic eosinophilic pleural effusion: a single-center experience

BMC Pulmonary Medicine, 2020
Background Eosinophilic pleural effusion (EPE) is attributed to several well-recognised causes. However, some patients remain idiopathic, even after thorough clinical work-up.
Weizhan Luo, Yunxiang Zeng, Panxiao Shen, Jianxing He, Jinlin Wang   +4 more
doaj   +1 more source

The impact of the COVID‐19 pandemic on the care of pulmonary hypertension patients outside the Hubei province in China

Pulmonary Circulation, 2022
The Coronavirus disease 2019 (COVID‐19) pandemic has severely affected the lives of people around the world, especially some patients with severe chronic diseases.
Yuqin Chen, Bihua Zhong, Qian Jiang, Yilin Chen, Wenjun He, Ning Lai, Dansha Zhou, Jiahao He, Yiting Yao, Yi Shen, Juan Li, Jianuo Yang, Zhe Zhang, Ran Ma, Jian Wang, Chunli Liu   +15 more
doaj   +1 more source

Endpoints in respiratory diseases [PDF]

European Journal of Clinical Pharmacology, 2010
A wide range of outcome measures or endpoints has been used in clinical trials to assess the effects of treatments in paediatric respiratory diseases. This can make it difficult to compare treatment outcomes from different trials and also to understand whether new treatments offer a real clinical benefit for patients.
DE BENEDICTIS FM, GUIDI R, CARRARO, SILVIA, BARALDI, EUGENIO   +3 more
openaire   +5 more sources